Meperidine is alive and well in the new millennium: Evaluation of meperidine usage patterns and frequency of adverse drug reactions

Pharmacotherapy

Volumn 24, Issue 6, 2004, Pages 776-783

  Seifert, Charles F ^a   Kennedy, Shalyn ^b  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b Department of Orthopaedic Surgery   (United States)

Author keywords

Adverse drug reactions; Meperidine; Pain management; Patient controlled analgesia; Renal function

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CODEINE; FENTANYL; MORPHINE; OXYCODONE; PETHIDINE;

AGED; ANALGESIA; ANXIETY DISORDER; CASE REPORT; COMPUTER SYSTEM; CONFUSION; CORRELATION ANALYSIS; CREATININE CLEARANCE; DISEASE DURATION; DOSE RESPONSE; DRUG SAFETY; DRUG USE; FEMALE; HALLUCINATION; HEALTH CARE POLICY; HIGH RISK POPULATION; HOSPITALIZATION; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; MUSCLE TWITCH; NERVOUSNESS; NEUROTOXICITY; PAIN; PATIENT CONTROLLED ANALGESIA; PRESCRIPTION; REVIEW; SEIZURE; STATISTICAL SIGNIFICANCE;

ADULT; AGED; AGED, 80 AND OVER; ANALGESIA, PATIENT-CONTROLLED; ANALGESICS, OPIOID; DRUG UTILIZATION REVIEW; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; KIDNEY FAILURE; MALE; MEPERIDINE; MIDDLE AGED; RISK ASSESSMENT; TEXAS;

EID: 2942584907     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.24.8.776.36066     Document Type: Review

References (19)

1. American Pain Society Quality of Care Committee. Quality improvement guidelines for the treatment of acute pain and cancer pain. JAMA 1995;274:1874-80.
2. Acute Pain Management Guideline Panel. Acute pain management: operative or medical procedures and trauma: clinical practice guideline. AHCPR publication no. 92-0032. Rockville, MD: Agency for Health Care Policy and Research, Public Health Service, U.S. Department of Health and Human Services, February 1992.
3. Gordon DB, Jones JD, Goshman LM, et al. A quality improvement approach to reducing use of meperidine. Joint Commission 2000;26:686-99.
4. Gutstein HB, Akil H. Opioid analgesics. In: Hardman JG, Limbird LE, eds. Goodman and Gilman's pharmacological basis of therapeutics, 10th ed. New York: McGraw-Hill, 2001:569-620.
5. Szeto H, Inturrisi C, Houde R, et al. Accumulation of normeperidine, an active metabolite of meperidine, in patients with renal failure or cancer. Ann Intern Med 1977;86:738-41.
6. Kaiko R, Foley K, Grabinski P, et al. Central nervous system excitatory effects of meperidine in cancer patients. Ann Neurol 1983;13:180-5.
7. Marcantonio ER, Juarez G, Goldman L, et al. The relationship of postoperative delirium with psychoactive medications. JAMA 1994;272:1518-21.
8. Geller RJ. Meperidine in patient-controlled analgesia: a near fatal mishap. Anesth Analg 1993;76:655-7.
9. Hagmeyer K, Mauro L, Mauro V. Meperidine-related seizures associated with patient-controlled analgesia pumps. Ann Pharmacother 1993;27:29-31.
10. Marinella M. Meperidine-induced generalized seizures with normal renal function. South Med J 1997;90:556-8.
11. Simopoulos T, Smith H, Peeters-Asdourian C, et al. Use of meperidine in patient-controlled analgesia and the development of a normeperidine toxic reaction. Arch Surg 2002;137:84-8.
12. Armstrong P, Bersten A. Normeperidine toxicity. Anesth Analg 1986;65:536-8.
13. Cole M, McCusker J, Dendukuri N, Han L. The prognostic significance of subsyndromal delirium in elderly medical inpatients. J Am Geriatr Soc 2003;51:754-60.
14. Vargas E, Terleira A, Hernando F, et al. Effect of adverse drug reactions on length of stay in surgical intensive care units. Crit Care Med 2003;31:694-8.
15. Sherman S, Lehman G. Opioids and the sphincter of Oddi. Gastrointest Endosc 1994;40:105-6.
16. Schumock G. Multifaceted approach to medication use policy development: the restriction of meperidine. Pharm Pract Manage Q 1997;16:66-78.
17. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
18. Naranjo CA, Busto A, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.
19. Somers, A, Petrovic M, Robays H, Bogaert M. Reporting adverse drug reactions on a geriatric ward: a pilot project. Eur J Clin Pharmacol 2003;58:707-14.